Details of the Drug Reposition

General Information of This Drug (ID: DMDXZ6O)

Drug Name
ALK-001   DMDXZ6O
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Stargardt disease DISPXOTO 9B70 Phase 2 [1]
Age-related macular degeneration DIS0XS2C 9B75.0 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT02402660) Tolerability and Effects of ALK-001 on Stargardt Disease. U.S. National Institutes of Health.